Non-interventional study of periinterventional fecal calprotectin of lower intestinal endoscopy as real world data (CALPRO-REAL)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00025193

Enrollment

150

Registered

2021-05-18

Start date

2021-04-11

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K58.1 K63.5

Interventions

Group 1: Patients with elective lower endoscopy (colonoscopy etc.) are compared from baseline fecal calprotectin concentration to their postinterventional values from d3 and d14.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Elective lower endoscopy

Exclusion criteria

Exclusion criteria: pregnancy, regular NSAID intake (> 2 DDD) the last 7 days before endoscopy and during study sampling, not available for stool samples afterwards, known nor suspected chronic inflammatory bowel disease, active colorectal cancer, suspected or definitive infectious diarrhea, gastrointestinal surgery within 6 months prior to endoscopy

Design outcomes

Primary

Measure	Time frame
difference of fecal calprotectin following lower intestinal endoscopy in comparison to baseline values	—

Secondary

Measure	Time frame
fecal calprotectin in correlation to indication of endocopy, type of endoscopy (colonoscopy, rectoscopy, ...), duration of endoscopy, adverse events of endoscopy, type of endoscopic intervention (polypectomy, tissue sampling, ...), CRP (blood levers), comobidities, medication	—

Countries

Germany

Contacts

Public ContactTobias Schlosser

Universitätsklinikum Leipzig

Tobias.Schlosser@medizin.uni-leipzig.de00403419712400

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026